{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:38:59Z","timestamp":1773801539705,"version":"3.50.1"},"reference-count":122,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2807,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.exphem.2014.07.268","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T12:51:09Z","timestamp":1410007869000},"page":"841-851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms"],"prefix":"10.1016","volume":"42","author":[{"given":"Janine","family":"Prick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2014.07.268_bib1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2353\/ajpath.2006.060312","article-title":"Hematopoietic stem cells: The paradigmatic tissue-specific stem cell","volume":"169","author":"Bryder","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.exphem.2014.07.268_bib2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cell.2011.05.033","article-title":"Strategies for homeostatic stem cell self-renewal in adult tissues","volume":"145","author":"Simons","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrc3184","article-title":"Cancer stem cells: An evolving concept","volume":"12","author":"Nguyen","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2014.07.268_bib4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1083\/jcb.201102131","article-title":"Cell cycle regulation in hematopoietic stem cells","volume":"195","author":"Pietras","year":"2011","journal-title":"J Cell Biol"},{"key":"10.1016\/j.exphem.2014.07.268_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0092-8674(85)80102-1","article-title":"Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W\/Wv mice","volume":"42","author":"Dick","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0092-8674(86)90566-0","article-title":"Developmental potential and dynamic behavior of hematopoietic stem cells","volume":"45","author":"Lemischka","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.stem.2012.05.006","article-title":"Hematopoietic stem cell heterogeneity takes center stage","volume":"10","author":"Copley","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.moh.0000231421.00407.65","article-title":"Clonal diversity of the stem cell compartment","volume":"13","author":"Muller-Sieburg","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2014.07.268_bib9","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.1110542","article-title":"Stem cells and their niches","volume":"311","author":"Moore","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.exphem.2014.07.268_bib10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood-2004-01-0282","article-title":"Competitive clonal hematopoiesis in mouse chimeras explained by a stochastic model of stem cell organization","volume":"105","author":"Roeder","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.stem.2007.05.015","article-title":"Long-term propagation of distinct hematopoietic differentiation programs in\u00a0vivo","volume":"1","author":"Dykstra","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.stem.2012.02.007","article-title":"Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs","volume":"10","author":"Benz","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib13","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1073\/pnas.1000834107","article-title":"Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion","volume":"107","author":"Beerman","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2014.07.268_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.stem.2010.02.002","article-title":"Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1","volume":"6","author":"Challen","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib15","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1182\/blood-2008-12-192054","article-title":"Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential","volume":"113","author":"Kent","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.20091318","article-title":"Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment","volume":"207","author":"Morita","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.exphem.2013.11.004","article-title":"Heterogeneity and hierarchy of hematopoietic stem cells","volume":"42","author":"Ema","year":"2014","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.07.268_bib18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature09650","article-title":"Genetic variegation of clonal architecture and propagating cells in leukaemia","volume":"469","author":"Anderson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.07.268_bib19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","article-title":"The causes and consequences of genetic heterogeneity in cancer evolution","volume":"501","author":"Burrell","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.07.268_bib21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/path.4270","article-title":"Implications of intratumour heterogeneity for treatment stratification","volume":"232","author":"Crockford","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.exphem.2014.07.268_bib22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature09733","article-title":"Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells","volume":"469","author":"Notta","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.07.268_bib24","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood.V68.6.1185.1185","article-title":"Clonogenic cells in acute myeloblastic leukemia","volume":"68","author":"Griffin","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib25","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1182\/blood-2008-08-077941","article-title":"Stem cell concepts renew cancer research","volume":"112","author":"Dick","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.07.268_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.10.012","article-title":"Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized","volume":"18","author":"Quintana","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2010.01.001","article-title":"Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells","volume":"6","author":"Charles","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1142596","article-title":"Tumor growth need not be driven by rare cancer stem cells","volume":"317","author":"Kelly","year":"2007","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.exphem.2014.07.268_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2184.36.s.1.6.x","article-title":"Stem cells in normal breast development and breast cancer","volume":"36","author":"Dontu","year":"2003","journal-title":"Cell Prolif"},{"key":"10.1016\/j.exphem.2014.07.268_bib32","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.2036535100","article-title":"Cancerous stem cells can arise from pediatric brain tumors","volume":"100","author":"Hemmati","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2014.07.268_bib33","first-page":"5821","article-title":"Identification of a cancer stem cell in human brain tumors","volume":"63","author":"Singh","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.07.268_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"O'Brien","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.07.268_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.exphem.2014.07.268_bib36","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0959-8049(09)70033-4","article-title":"Cancer stem cells and the cellular hierarchy in haematological malignancies","volume":"45","author":"Johnsen","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.exphem.2014.07.268_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11899-011-0085-y","article-title":"In search of CML stem cells' deadly weakness","volume":"6","author":"Pellicano","year":"2011","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.exphem.2014.07.268_bib38","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders","volume":"355","author":"Campbell","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib39","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM197610212951702","article-title":"Polycythemia vera: stem-cell and probable clonal origin of the disease","volume":"295","author":"Adamson","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib40","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V58.5.916.916","article-title":"Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell","volume":"58","author":"Fialkow","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/blood.V51.2.189.189","article-title":"Agnogenic myeloid metaplasia: A clonal proliferation of hematopoietic stem cells with secondary myelofibrosis","volume":"51","author":"Jacobson","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib42","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2014.07.268_bib43","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.07.268_bib44","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib46","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1182\/blood-2010-11-316810","article-title":"Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations","volume":"117","author":"Passamonti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib48","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib49","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1182\/blood-2013-02-486050","article-title":"Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms","volume":"121","author":"Rumi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib50","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib51","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2","volume":"369","author":"Nangalia","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/asheducation-2003.1.200","article-title":"Chronic myeloproliferative disorders","author":"Spivak","year":"2003","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.exphem.2014.07.268_bib53","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2012-05-431791","article-title":"JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone","volume":"120","author":"Godfrey","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2141.2006.06288.x","article-title":"JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders","volume":"135","author":"Rossi","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2014.07.268_bib55","doi-asserted-by":"crossref","first-page":"e1001576","DOI":"10.1371\/journal.pbio.1001576","article-title":"Self-renewal of single mouse hematopoietic stem cells is reduced by JAK2V617F without compromising progenitor cell expansion","volume":"11","author":"Kent","year":"2013","journal-title":"PLoS Biol"},{"key":"10.1016\/j.exphem.2014.07.268_bib56","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/leu.2008.236","article-title":"Aberrant signal transduction\u00a0pathways in myeloproliferative neoplasms","volume":"22","author":"Kota","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.07.268_bib57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11899-013-0184-z","article-title":"Genetic basis of MPN: Beyond JAK2-V617F","volume":"8","author":"Them","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.exphem.2014.07.268_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/PPO.0000000000000013","article-title":"Genetics of myeloproliferative neoplasms","volume":"20","author":"Viny","year":"2014","journal-title":"Cancer J"},{"key":"10.1016\/j.exphem.2014.07.268_bib59","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood-2010-02-270108","article-title":"Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms","volume":"116","author":"Oh","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib60","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature08240","article-title":"Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms","volume":"460","author":"Sanada","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.07.268_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.07.268_bib62","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/gcc.21960","article-title":"Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms","volume":"51","author":"Brecqueville","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2014.07.268_bib63","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/0008-5472.CAN-09-3783","article-title":"Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias","volume":"70","author":"Abdel-Wahab","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.07.268_bib64","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","article-title":"Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms","volume":"123","author":"Lundberg","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib65","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/leu.2013.119","article-title":"Mutations and prognosis in primary myelofibrosis","volume":"27","author":"Vannucchi","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.07.268_bib66","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1515\/cclm-2013-0135","article-title":"Molecular basis and clonal evolution of myeloproliferative neoplasms","volume":"51","author":"Cleary","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib67","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMc1012718","article-title":"P53 Lesions in leukemic transformation","volume":"364","author":"Harutyunyan","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib68","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/leu.2014.3","article-title":"CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: Clinical, cytogenetic and molecular comparisons","volume":"28","author":"Tefferi","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.07.268_bib69","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1182\/blood-2014-02-554634","article-title":"Integrated genomic analysis illustrates the central role of JAK\u2013STAT pathway activation in myeloproliferative neoplasm pathogenesis","volume":"123","author":"Rampal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib70","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1182\/blood-2010-08-270033","article-title":"How I treat essential thrombocythemia","volume":"117","author":"Beer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib71","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2007-05-091850","article-title":"Bone marrow pathology in essential thrombocythemia: Interobserver reliability and utility for identifying disease subtypes","volume":"111","author":"Wilkins","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib72","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1242\/dmm.006817","article-title":"Mouse models of myeloproliferative neoplasms: JAK of all grades","volume":"4","author":"Li","year":"2011","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.exphem.2014.07.268_bib73","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3324\/haematol.2010.035675","article-title":"The Ph-positive and Ph-negative myeloproliferative neoplasms: Some topical pre-clinical and clinical issues","volume":"96","author":"Van Etten","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2014.07.268_bib74","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood-2009-04-215848","article-title":"Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease","volume":"115","author":"Akada","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib75","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2009-12-257063","article-title":"Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice","volume":"116","author":"Marty","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib76","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccr.2010.05.015","article-title":"Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib77","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1182\/blood-2009-12-259747","article-title":"JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia","volume":"116","author":"Li","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib78","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1182\/blood-2012-03-415646","article-title":"Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model","volume":"121","author":"Kubovcakova","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib79","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1182\/blood-2012-01-402396","article-title":"Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera","volume":"120","author":"Mullally","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib80","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood-2006-04-018259","article-title":"Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera,\u00a0but not essential thrombocythemia","volume":"108","author":"Scott","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib81","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood-2013-06-510222","article-title":"JAK2V617F-homozygosity drives a phenotypic switch between myeloproliferative neoplasms in a murine model, but is insufficient to sustain clonal expansion","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib82","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.exphem.2009.09.009","article-title":"Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation","volume":"37","author":"Laubach","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.07.268_bib83","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc2210","article-title":"Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders","volume":"7","author":"Levine","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2014.07.268_bib84","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2010.10.013","article-title":"Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling","volume":"18","author":"Chen","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.07.268_bib85","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1074\/jbc.M109.040733","article-title":"STAT5 activation is critical for the transformation mediated by myeloproliferative disorder-associated JAK2 V617F mutant","volume":"285","author":"Funakoshi-Tago","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2014.07.268_bib86","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1182\/blood-2011-03-345215","article-title":"Critical requirement for Stat5 in a mouse model of polycythemia vera","volume":"119","author":"Yan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib87","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1182\/blood-2011-12-397554","article-title":"Essential role for Stat5a\/b\u00a0in\u00a0myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice","volume":"119","author":"Walz","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib88","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0140-6736(88)92625-6","article-title":"Treatment of essential thrombocythaemia by alpha 2a interferon","volume":"2","author":"Bellucci","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2014.07.268_bib89","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(88)92881-4","article-title":"Recombinant interferon-alpha for treatment of polycythaemia vera","volume":"2","author":"Silver","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2014.07.268_bib90","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2008-03-143537","article-title":"Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera","volume":"112","author":"Kiladjian","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib91","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1200\/JCO.2009.23.6075","article-title":"Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera","volume":"27","author":"Quintas-Cardama","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2014.07.268_bib92","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature07815","article-title":"IFNalpha activates dormant haematopoietic stem cells in\u00a0vivo","volume":"458","author":"Essers","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2014.07.268_bib93","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nm.1973","article-title":"Interferon regulatory factor-2 protects quiescent hematopoietic stem cells\u00a0from type I interferon-dependent exhaustion","volume":"15","author":"Sato","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib94","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood-2013-04-498956","article-title":"JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNalpha","volume":"122","author":"Hasan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib95","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1182\/blood-2012-05-432989","article-title":"Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-alpha in a murine model of polycythemia vera","volume":"121","author":"Mullally","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib96","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2040620713489144","article-title":"Inherited predisposition to myeloproliferative neoplasms","volume":"4","author":"Jones","year":"2013","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.exphem.2014.07.268_bib97","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1182\/blood-2003-03-0885","article-title":"Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease","volume":"102","author":"Kralovics","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib98","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood-2008-03-077966","article-title":"Myeloproliferative disorders","volume":"112","author":"Levine","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib99","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng.334","article-title":"JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms","volume":"41","author":"Jones","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2014.07.268_bib100","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1182\/blood-2007-06-095703","article-title":"Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders","volume":"111","author":"Pardanani","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib101","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0002-9343(77)90124-3","article-title":"Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte\/macrophage","volume":"63","author":"Fialkow","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib102","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood-2006-03-009472","article-title":"JAK2(V617F): Prevalence in a large Chinese hospital population","volume":"109","author":"Xu","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib103","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.exphem.2013.03.007","article-title":"Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: A biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy","volume":"41","author":"Ruella","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.07.268_bib104","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.exphem.2007.07.005","article-title":"Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD\/SCID mice","volume":"35","author":"Ishii","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.07.268_bib105","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood-2005-12-013748","article-title":"Mutation of JAK2 in the myeloproliferative disorders: Timing, clonality studies, cytogenetic associations, and role in leukemic transformation","volume":"108","author":"Campbell","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib106","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2006-12-062125","article-title":"Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation","volume":"110","author":"Theocharides","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib107","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3324\/haematol.2011.059113","article-title":"Erythroid lineage-restricted expression of Jak2V617F is sufficient to induce a myeloproliferative disease in mice","volume":"97","author":"Akada","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2014.07.268_bib108","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri1779","article-title":"Bone-marrow haematopoietic-stem-cell niches","volume":"6","author":"Wilson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2014.07.268_bib109","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/blood-2010-12-327593","article-title":"Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasms","volume":"118","author":"Anand","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib110","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood-2008-02-137877","article-title":"The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity","volume":"112","author":"James","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib111","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1073\/pnas.0601462103","article-title":"The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation","volume":"103","author":"Jamieson","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2014.07.268_bib112","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.exphem.2008.05.006","article-title":"Phenotypic variability within the JAK2 V617F-positive MPD: Roles of progenitor cell and neutrophil allele burdens","volume":"36","author":"Moliterno","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.07.268_bib113","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/leu.2010.159","article-title":"Insights into the stem cells of chronic myeloid leukemia","volume":"24","author":"Sloma","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.07.268_bib114","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte\u2013macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib115","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood.V87.4.1539.bloodjournal8741539","article-title":"Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis","volume":"87","author":"Sirard","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib116","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11912-013-0339-z","article-title":"Acute promyelocytic leukemia: Do we have a new front-line standard of treatment?","volume":"15","author":"Sanz","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.exphem.2014.07.268_bib117","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.exphem.2011.11.003","article-title":"Homeostasis of hematopoietic stem cells regulated by the myeloproliferative disease associated-gene product Lnk\/Sh2b3 via Bcl-xL","volume":"40","author":"Suzuki","year":"2012","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2014.07.268_bib118","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1182\/blood-2011-02-336743","article-title":"Efficacy of vorinostat in a murine model of polycythemia vera","volume":"119","author":"Akada","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.07.268_bib119","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1084\/jem.20112087","article-title":"Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranks","volume":"208","author":"Pellicano","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2014.07.268_bib120","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/leu.2009.141","article-title":"Mutations of ASXL1 gene in myeloproliferative neoplasms","volume":"23","author":"Carbuccia","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.07.268_bib121","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pbio.1000059","article-title":"Oncogenic Kras initiates leukemia in hematopoietic stem cells","volume":"7","author":"Sabnis","year":"2009","journal-title":"PLoS Biol"},{"key":"10.1016\/j.exphem.2014.07.268_bib122","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1182\/blood-2009-04-215376","article-title":"BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells","volume":"115","author":"Schemionek","year":"2010","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X14006225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X14006225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:31:46Z","timestamp":1759566706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X14006225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":122,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0301472X14006225"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2014.07.268","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2014.07.268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}